New Insights on Hyperbaric Oxygen Therapy for Cancer
- Authors
-
-
Michael J. González
University of Puerto Rico, Medical Sciences Campus, School of Public Health, USA; EDP University, Naturopathic Sciences Program, USA; Universidad Central del Caribe, School of Chiropractic, USA; Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA and Berdiel Clinic, Ponce Puerto Rico, USA -
Jorge R. Miranda-Massari
University of Puerto Rico, Medical Sciences Campus, School of Pharmacy, USA and EDP University, Naturopathic Sciences Program, USA -
Michael Joseph Gonzalez
Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA -
Jose Olalde
Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA -
Miguel J. Berdiel
Berdiel Clinic, Ponce Puerto Rico, USA -
Liza Cardona
EDP University, Naturopathic Sciences Program, USA
-
- Keywords:
- Hyperbaric Oxygen, Cancer, oxygen, degenerative diseases, hypoxia, senesence
- Abstract
-
Hypoxia is a critical characteristic of malignant tumors and involves enhanced cell survival, angiogenesis, glycolytic metabolism, and metastasis. Hyperbaric oxygen treatment (HBOT) has been used to improve and cure disorders involving hypoxia and ischemia, HBOT enhances the amount of dissolved oxygen in the plasma and thereby increasing O2 delivery to the tissue. Studies on HBOT and cancer have mostly focused on whether enhanced oxygen may act as a promoter of cancer. As oxygen is believed to be required for all the major processes of wound healing, including angiogenesis, this particular idea would give the impression that HBOT will promote cancer growth and recurrence. Nevertheless, this is not the case since the use of HBOT in patients with malignancies should be considered safe and therapeutic. There is no evidence indicating that HBO neither acts as a stimulator of tumor growth nor as an enhancer of recurrence. On the other hand, there is evidence that implies that HBO has tumor-inhibitory effects, this manuscript pretends to expand our knowledge on the effect and the mechanisms behind tumor oxygenation by HBOT.
- References
-
Chen SY, Tsuneyama K, Yen MH, Lee JT, Chen JL, Huang SM. Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer. Sci Rep 2021; 11(1):12033. https://doi.org/10.1038/s41598-021-91454-2
Manish KC, Rodriguez JR, Gonzalez FL, Arroyo NA, Garcia KM, Olalde J, Berdiel MJ, Morales-Borges R, Miranda-Massari JR, Gonzalez MJ. Research advances in hyperbaric oxygen therapy use in cancer: A Review. Am Res J Oncology 2021; 3(1): 1-6.
Poff AM, Ari C, Seyfried TN, D'Agostino DP. The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One 2013; 8(6): e65522. https://doi.org/10.1371/journal.pone.0065522
Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer a review. Target Oncol 2012; 7(4): 233-42. https://doi.org/10.1007/s11523-012-0233-x
Daruwalla J, Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J Surg 2006; 30(12): 2112-31. https://doi.org/10.1007/s00268-006-0190-6
Herrera-Campos AB, Zamudio-Martinez E, Delgado-Bellido D, Fernández-Cortés M, Montuenga LM, Oliver FJ, Garcia-Diaz A. Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System. Cancers (Basel) 2022; 14(11): 2740. https://doi.org/10.3390/cancers14112740
Narkowicz C K, Vial JH and McCartney PW. Hyperbaric Oxygen Therapy Increases Free Radical Levels in the Blood of Humans, Free Radical Research Communications 1993; 19(2): 71-80. https://doi.org/10.3109/10715769309056501
Weber SU, Koch A, Kankeleit J, Schewe JC, Siekmann U, Stüber F, Hoeft A, Schröder S. Hyperbaric oxygen induces apoptosis via a mitochondrial mechanism. Apoptosis 2009; 14(1): 97-107. https://doi.org/10.1007/s10495-008-0280-z
Gonzalez MJ, Seyfried T, Nicolson GL, Barclay BJ, Matta J, Vasquez A, D’ Agostino D, Olalde J, Duconge J, Hunninghake R, Berdiel MJ, Cintrón A. Mitochondrial Correction: A New Therapeutic Paradigm for Cancer and Degenerative Diseases. J Orthomolec Med 2018; 33(4): 1-20.
Hadanny A, Forer R, Volodarsky D, Daniel-Kotovsky M, Catalogna M, Zemel Y, Bechor Y, Efrati S. Hyperbaric oxygen therapy induces transcriptome changes in elderly: a prospective trial. Aging (Albany NY) 2021; 13(22): 24511-24523. https://doi.org/10.18632/aging.203709
Gupta K, Madan E, Sayyid M, Arias-Pulido H, Moreno E, Kuppusamy P, Gogna R. Oxygen regulates molecular mechanisms of cancer progression and metastasis. Cancer Metastasis Rev 2014; 33(1): 183-215. https://doi.org/10.1007/s10555-013-9464-2
Dave KR, Prado R, Busto R, Raval AP, Bradley WG, Torbati D, Pérez-Pinzón MA. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice. Neuroscience 2003; 120(1): 113-120. https://doi.org/10.1016/S0306-4522(03)00244-6
Rossignol DA, Bradstreet JJ, Van Dyke K, Schneider C, Freedenfeld SH, O’Hara N, Cave S, Buckley JA, Mumper EA, Frye RE. Hyperbaric oxygen treatment in autism spectrum disorders. Med Gas Res 2012; 2(16). https://doi.org/10.1186/2045-9912-2-16
Palzur E, Zaaroor M, Vlodavsky E, Milman F, Soustiel JF. Neuroprotective effect of hyperbaric oxygen therapy in brain injury is mediated by preservation of mitochondrial membrane properties. Brain Res 2008; 1221: 126-133. https://doi.org/10.1016/j.brainres.2008.04.078
Poff AM, Ward N, Seyfried TN, Arnold P, D’Agostino DP. Non-toxic metabolic management of metastatic cancer in VM mice: novel combination of ketogenic diet, ketone supplementation and hyperbaric oxygen therapy. PLoS One 2015; 10: e0127407. https://doi.org/10.1371/journal.pone.0127407
Lin PY, Sung PH, Chung SY, Hsu SL, Chung WJ, Sheu JJ, Hsueh SK, Chen KH, Wu RW, Yip HK. Hyperbaric Oxygen Therapy Enhanced Circulating Levels of Endothelial Progenitor Cells and Angiogenesis Biomarkers, Blood Flow, in Ischemic Areas in Patients with Peripheral Arterial Occlusive Disease. J Clin Med 2018; 7(12): 548. https://doi.org/10.3390/jcm7120548
Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother 2019; 109: 440-447. https://doi.org/10.1016/j.biopha.2018.10.142
Yang C, Liu G, Zeng X, Xiang Y, Chen X, Le W. Therapeutic effects of long-term HBOT on Alzheimer's disease neuropathologies and cognitive impairment in APPswe/PS1dE9 mice. Redox Biol 2024; 70: 103006. https://doi.org/10.1016/j.redox.2023.103006
Hink J, Jansen E. Are superoxide and/or hydrogen peroxide responsible for some of the beneficial effects of hyperbaric oxygen therapy? Medical Hypotheses 2001; 57: 764-769. https://doi.org/10.1054/mehy.2001.1488
- Downloads
- Published
- 2024-06-12
- Issue
- Vol. 13 (2024)
- Section
- Articles
- License
-

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- K. Pushkala, P.D. Gupta, Increased Incidence of Breast Cancer Due to Long Exposure of Light , Journal of Analytical Oncology: Vol. 5 No. 4 (2016)
- Tanmoy Bhowmik, Ajoy Kumar Biswas, Amrita Sarkar, Partha Pratim Saha, Aparna Gomes, Antony Gomes , Caspase Pathway Activation and Reactive Oxygen Species Generation in Apoptotic Cell Death of Human Leukemic U937 and K562 Cell Line in Response to King Cobra (Ophiophagus hannah) Venom , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- James H. Tabibian, Keith D. Lindor, Challenges of Cholangiocarcinoma Detection in Patients with Primary Sclerosing Cholangitis , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- Ahmad Salimi, Mehrnoush Pir Saharkhiz, Abbasali Motallebi, Enayatollah Seydi, Ali Reza Mohseni, Melika Nazemi , Jalal Pourahmad, Standardized Extract of the Persian Gulf Sponge, Axinella Sinoxea Selectively Induces Apoptosis through Mitochondria in Human Chronic Lymphocytic Leukemia Cells , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Kanupriya Gupta, T.P. Chaturvedi, Jatin Gupta, Glypicans - A Brief Review , Journal of Analytical Oncology: Vol. 8 (2019)
- Kazuya Kuraoka, Kiyomi Taniyama, Miho Tanaka, Yukari Nakagawa, Naoko Yasumura, Tamaki Toda, Mikie Shitaune, Akihisa Saito, Junichi Sakane, Yoko Kodama, Toshinao Nishimura, Nao Morii, Hirotoshi Takahashi , Hiroyasu Yamashiro , Auto-Analysis for Ki-67 Indices of Breast Cancer Using Specified Computer Software and a Virtual Microscopy , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Laurence A. Cole, Hyperglycosylated hCG Drives Malignancy in Most or All Human Cancers: Tying All Research Together , Journal of Analytical Oncology: Vol. 7 No. 1 (2018)
- Paola Castro-Garcia, Carmen Gil-Gas, Paloma Honrubia-Gómez, Carmen Belen Alvarez-Simón, Jesús-José Ferré-Fernández, Francisco Sánchez-Sánchez, Jose Luis Sánchez-Sánchez, Jose Mª Garcia-Bueno, Sebastiá Sabater, Guadalupe Aparicio, Luis Miguel Antón-Aparicio, Carmen Ramírez-Castillejo, C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Eelco R.P. Collette, Monique J. Roobol, Prostate Cancer Treatment on the Basis of an Individual Risk Profile; Can we Reduce Overtreatment? , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Juan Pablo Nicola, Ana María Masini-Repiso, Emerging Therapeutics for Radioiodide-Refractory Thyroid Cancer , Journal of Analytical Oncology: Vol. 5 No. 2 (2016)
You may also start an advanced similarity search for this article.
